Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age-Related Macular Degeneration (ARMD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT05605782
What this trial is testing

A Post-Authorization, Long-term Study of Ozanimod Real-world Safety

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Bristol-Myers Squibb 9,000
Large-scale testing (Phase 3)Study completedNCT05587062
What this trial is testing

Efficacy and Safety of Aflibercept in Patients With Neovascular Age-related Macular Degeneration

Who this might be right for
Age-Related Macular DegenerationNeovascular Age-related Macular Degeneration
Cinnagen 168
Large-scale testing (Phase 3)Study completedNCT03150589
What this trial is testing

Compare SB11 (Proposed Ranibizumab Biosimilar) to Lucentis in Subjects With Neovascular Age-related Macular Degeneration (AMD)

Who this might be right for
Age-Related Macular Degeneration
Samsung Bioepis Co., Ltd. 705
Not applicableUnknownNCT03061682
What this trial is testing

Implantation of Add on Lens for Age Related Macular Degeneration Patients With Low Vision

Who this might be right for
Inclusion Criteria
Rabin Medical Center 20
Large-scale testing (Phase 3)Study completedNCT04423718
What this trial is testing

Study of the Effects of High Dose Aflibercept Injected Into the Eye of Patients With an Age-related Disorder That Causes Loss of Vision Due to Growth of Abnormal Blood Vessels at the Back of the Eye

Who this might be right for
Neovascular Age-Related Macular Degeneration
Bayer 1,011
Testing effectiveness (Phase 2)Study completedNCT02358889
What this trial is testing

Study Evaluating Intravitreal hI-con1™ in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration

Who this might be right for
Choroidal NeovascularizationAge-related Macular Degeneration
Iconic Therapeutics, Inc. 88
Testing effectiveness (Phase 2)Study completedNCT00306488
What this trial is testing

OT-551 Antioxidant Eye Drops to Treat Geographic Atrophy in Age-Related Macular Degeneration

Who this might be right for
Geographic AtrophyAge-Related Macular DegenerationAMD
National Institutes of Health Clinical Center (CC) 11
Post-approval studies (Phase 4)Study completedNCT02953938
What this trial is testing

Study to Show a Superior Benefit in Terms of Reduction of Ranibizumab Injections in Patients Receiving Ranibizumab Plus Laser Photocoagulation Combination Therapy Without Loss of Efficacy and Safety

Who this might be right for
Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO)
Novartis Pharmaceuticals 59
Testing effectiveness (Phase 2)Ended earlyNCT02087085
What this trial is testing

A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration

Who this might be right for
Geographic AtrophyMacular Degeneration
Allergan 310
Not applicableStudy completedNCT04390126
What this trial is testing

COVID-19 Related Lockdown Effects On Chronic Diseases

Who this might be right for
Chronic Coronary SyndromeHeart FailureAMD and Macular Edema+5 more
Centre Hospitalier Universitaire Dijon 1,343
Early research (Phase 1)Looking for participantsNCT06395285
What this trial is testing

Evaluating the Safety and Tolerability of Orally Administered DF-003 in ROSAH Syndrome Patients

Who this might be right for
ROSAH
Shanghai Yao Yuan Biotechnology Ltd. (also known as Drug Farm) 12
Not applicableStudy completedNCT04909398
What this trial is testing

Pupil Dynamics and Color Vision for the Detection of Eye Diseases

Who this might be right for
Retinitis PigmentosaLeber's Hereditary Optic NeuropathyStargardt Disease
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts 60
Testing effectiveness (Phase 2)Looking for participantsNCT07392255
What this trial is testing

An Optimised GA Interventional Trial (Opti-GAIN) to Test if Treatment With CTx001 is Safe and Works for People With Geographic Atrophy (GA)

Who this might be right for
Geographic Atrophy Secondary to Age-related Macular Degeneration
Complement Therapeutics 75
Not applicableLooking for participantsNCT01496625
What this trial is testing

National Eye Institute Biorepository for Retinal Diseases

Who this might be right for
Age-Related Macular DegenerationDiabetic RetinopathyVon Hippel-Lindau Syndrome+2 more
National Eye Institute (NEI) 650
Not applicableStudy completedNCT01644513
What this trial is testing

Evaluation of the Association Between Genetic Load and Response to Anti-VEGF Therapy in AMD Patients

Who this might be right for
Age Related Macular Degeneration
Sequenom, Inc. 196
Large-scale testing (Phase 3)Active Not RecruitingNCT06556368
What this trial is testing

Evaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafusp Tedromer Compared to Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD) - DAYBREAK

Who this might be right for
Wet Age-related Macular Degeneration
Kodiak Sciences Inc 675
Large-scale testing (Phase 3)Study completedNCT03386474
What this trial is testing

Study of Safety and Efficacy of Brolucizumab 6 mg Drug Product Intended for Commercialization in Patients With nAMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals 151
Large-scale testing (Phase 3)Study completedNCT05604989
What this trial is testing

Associations Between the Oral and Intestinal Microbiome and Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
Seoul National University Bundang Hospital 45
Early research (Phase 1)Study completedNCT00121589
What this trial is testing

Lutein/Zeaxanthin and Omega-3 Supplementation in Persons Over Age 60

Who this might be right for
Macular Degeneration
National Eye Institute (NEI) 40
Not applicableStudy completedNCT01783925
What this trial is testing

Eylea Post Marketing Surveillance(PMS)

Who this might be right for
Macular Degeneration
Bayer 3,206
Next Page